Approval · Notice of Compliance 33852 · 2024
ACCRUFER: Notice of Compliance 33852
Issued August 21, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33852
- Date
- August 21, 2024
- Company
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCRUFER | 02550679 | Marketed |
Medicinal ingredients
- FERRIC MALTOL 30 MG per CAP